
Feb 6 (Reuters) - Bristol-Myers Squibb Co BMY.N:
Q4 ADJUSTED EPS $1.67 VERSUS IBES ESTIMATE $1.46
Q4 REVENUE $12.34 BILLION VERSUS IBES ESTIMATE $11.57 BILLION
OUTLOOK 2025 ADJUSTED EPS $6.55 TO $6.85 VERSUS IBES ESTIMATE $6.92
EXPANDS STRATEGIC PRODUCTIVITY INITIATIVE TO DELIVER ABOUT $2 BILLION IN ADDITIONAL COST SAVINGS BY2027 END
OUTLOOK 2025 REVENUES OF ABOUT $45.5 BILLION VERSUS IBES ESTIMATE $47.36 BILLION